More Globe Newswire

View Older Stories View Newer Stories

Mar 25, 2025 05:00PM CAPREIT Announces Timing of First Quarter 2025 Results & Conference Call

Mar 25, 2025 05:00PM ERES Announces Timing of First Quarter 2025 Results & Conference Call

Mar 25, 2025 05:00PM Saturn Oil & Gas Inc. Announces Participation in Virtual Investor Conference on March 27th

Mar 25, 2025 05:00PM Weatherford Releases 2024 Digital Annual Update

Mar 25, 2025 05:00PM Element Nominates Paolo Ferrari and Tracey McVicar for Election to the Board of Directors

Mar 25, 2025 05:00PM Saturn Oil & Gas Inc. Announces Participation in Virtual Investor Conference on March 27th

Mar 25, 2025 05:00PM Bombardier Defense Announces Order of Two Challenger 650 Aircraft Destined for Intelligence, Surveillance and Reconnaissance missions in Australia

Mar 25, 2025 04:55PM CISO Global Announces Pay Off of Highest-Interest Debt, Extends $7M in Convertible Notes

Mar 25, 2025 04:45PM Bicara Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2025

Mar 25, 2025 04:45PM W&T Offshore Announces Management Promotion

Mar 25, 2025 04:45PM Blueberries Medical Announces C$1 Million Non-Brokered Private Placement

Mar 25, 2025 04:40PM Freddie Mac Issues Monthly Volume Summary for February 2025

Mar 25, 2025 04:40PM Zentalis Pharmaceuticals to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025

Mar 25, 2025 04:38PM True North Mortgage Welcomes 25+ Former Rocket Mortgage Canada Employees, Expands Windsor and Quebec Presence

Mar 25, 2025 04:35PM IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Mar 25, 2025 04:35PM iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025

Mar 25, 2025 04:35PM Foghorn Therapeutics Announces New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and EP300 Degrader Programs at 2025 AACR Meeting

Mar 25, 2025 04:31PM Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting

Mar 25, 2025 04:31PM Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting

Mar 25, 2025 04:31PM Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at the 2025 AACR Annual Meeting

Mar 25, 2025 04:30PM Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting

Mar 25, 2025 04:30PM Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting

Mar 25, 2025 04:30PM NeOnc Technologies Holdings Announces Effectiveness of Registration Statement and Anticipated Listing Date of Common Stock on Nasdaq Global Market

Mar 25, 2025 04:30PM Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025

Mar 25, 2025 04:30PM Nouscom to Present Final Results from Successful Phase Ib/II Trial of NOUS-209 in People Living with Lynch Syndrome, Demonstrating Powerful Potential to Intercept Cancer in its Earliest Stages of Deve

Mar 25, 2025 04:30PM Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025

Mar 25, 2025 04:30PM Farmers & Merchants Bancorp, Inc. Declares 2025 First-Quarter Cash Dividend

Mar 25, 2025 04:30PM Media Advisory — Newport News Shipbuilding Apprentice School to Host Commencement Ceremony for 2024 Graduates

Mar 25, 2025 04:30PM Nurix Therapeutics Announces Multiple Presentations at the American Association for Cancer Research (AACR) 2025 Annual Meeting

Mar 25, 2025 04:30PM Affimed Announces Acceptance of AFM24 Abstract on Dose Optimization for Presentation at American Association for Cancer Research Annual Meeting

Mar 25, 2025 04:30PM Quanta Therapeutics Announces Late-Breaking Presentation of QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025

Mar 25, 2025 04:30PM Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025

Mar 25, 2025 04:30PM ECD Auto Design Reports Third Quarter 2024 Financial Results; Revenues Increase 30% to $6.4 Million

Mar 25, 2025 04:30PM CLEAR and American Express Renew Partnership to Provide Premium Travel Experiences at Airports to Card Members

Mar 25, 2025 04:30PM Farmers & Merchants Bancorp, Inc. Declares 2025 First-Quarter Cash Dividend

Mar 25, 2025 04:30PM Coherus to Present Data from a Phase 1 Dose Expansion Study of CHS-114, a Cytolytic Antibody Targeting Chemokine Receptor 8 (CCR8), at the 2025 American Association for Cancer Research (AACR) Annual M

Mar 25, 2025 04:30PM Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Mar 25, 2025 04:30PM Tempest Announces Amezalpat Poster Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Mar 25, 2025 04:30PM ORIC® Pharmaceuticals Announces ORIC-944 Preclinical Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Mar 25, 2025 04:30PM T-knife Therapeutics Announces Five Presentations at American Association for Cancer Research (AACR) Annual Meeting

Mar 25, 2025 04:30PM Nouscom to Present Final Results from Successful Phase Ib/II Trial of NOUS-209 in People Living with Lynch Syndrome, Demonstrating Powerful Potential to Intercept Cancer in its Earliest Stages of Deve

Mar 25, 2025 04:30PM Nokia Corporation: Repurchase of own shares on 25.03.2025

Mar 25, 2025 04:25PM Global Water Announces Proposed Public Offering of Common Stock

Mar 25, 2025 04:20PM WeRide Inc. Files Its 2024 Annual Report on Form 20-F

Mar 25, 2025 04:18PM Draganfly to Host Shareholder Update Call on March 27, 2025

Mar 25, 2025 04:15PM Lendmark Financial Services Opens its 54th Georgia Branch in Vidalia, Marking its Eighth Portfolio Branch Opening in 2025

Mar 25, 2025 04:15PM Worthington Enterprises Reports Third Quarter Fiscal 2025 Results

Mar 25, 2025 04:15PM ARMOUR Residential REIT, Inc. Announces Guidance for April 2025 Dividend Rate Per Common Share

Mar 25, 2025 04:15PM Stryker announces Annual Meeting of Shareholders

Mar 25, 2025 04:15PM Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference

View Newer Stories View Older Stories